Dr. Richard Polin’s Neonatology Questions and Controversies series highlights the most challenging aspects of neonatal care, offering trustworthy guidance on up-to-date diagnostic and treatment options in the field. In each volume, renowned experts address the clinical problems of greatest concern to today’s practitioners, helping you handle difficult practice issues and provide optimal, evidence-based care to every patient.
Purchase each volume individually, or get the entire 7-volume set!Gastroenterology and NutritionHematology, Immunology and GeneticsHemodynamics and CardiologyInfectious Disease and Pharmacology New Volume!Nephrology and Fluid/Electrolyte PhysiologyNeurologyThe Newborn Lung
1. Cover image - p. iii 2. Title Page - p. iii 3. Table of Contents - p. iii 4. Series page - p. ii 5. Copyright - p. iv 6. Contributors - p. v 7. Series Foreword - p. ix 8. Preface - p. xi 9. Section A Infectious Disease - p. xi 10. Chapter 1 Management of the Asymptomatic Newborn at Risk for Sepsis - p. 3 11. Chapter 2 Empiric Antimicrobials for Neonatal Sepsis - p. 15 12. Chapter 3 When and How to Treat Neonatal CMV Infection - p. 27 13. Chapter 4 Neonatal Herpes Simplex Virus Infection - p. 37 14. Chapter 5 Antibiotic Stewardship - p. 45 15. Chapter 6 Candida Prophylaxis - p. 63 16. Chapter 7 Diagnosis, Risk Factors, Outcomes, and Evaluation of Invasive Candida Infections - p. 69 17. Chapter 8 When to Perform Lumbar Puncture in Infants at Risk for Meningitis in the Neonatal Intensive Care Unit - p. 87 18. Chapter 9 Biomarkers in the Diagnosis of Neonatal Sepsis - p. 103 19. Chapter 10 Congenital Zika Syndrome - p. 113 20. Section B Pharmacology - p. 120 21. Chapter 11 Pharmacokinetic Considerations in Neonates - p. 123 22. Chapter 12 Neonatal Pharmacogenetics - p. 141 23. Chapter 13 Antibiotic Considerations for Necrotizing Enterocolitis - p. 155 24. Chapter 14 Antibiotic Dosing Considerations for Term and Preterm Infants - p. 167 25. Chapter 15 Antifungal Dosing Considerations for Term and Preterm Infants - p. 185 26. Chapter 16 Antiviral Dosing Considerations for Term and Preterm Infants - p. 193 27. Chapter 17 Antiepileptic Drug Therapy in Neonates - p. 207 28. Chapter 18 Neuroprotective Therapies in Infants - p. 227 29. Chapter 19 Pharmacologic Therapy for Neonatal Abstinence Syndrome - p. 243 30. Chapter 20 Therapies for Gastroesophageal Reflux in Infants - p. 261 31. Index - p. 279
No hay muestra disponible
No hay ficha técnica disponible
Dr. Richard Polin’s Neonatology Questions and Controversies series highlights the most challenging aspects of neonatal care, offering trustworthy guidance on up-to-date diagnostic and treatment options in the field. In each volume, renowned experts address the clinical problems of greatest concern to today’s practitioners, helping you handle difficult practice issues and provide optimal, evidence-based care to every patient.
Purchase each volume individually, or get the entire 7-volume set!Gastroenterology and NutritionHematology, Immunology and GeneticsHemodynamics and CardiologyInfectious Disease and Pharmacology New Volume!Nephrology and Fluid/Electrolyte PhysiologyNeurologyThe Newborn Lung
1. Cover image - p. iii 2. Title Page - p. iii 3. Table of Contents - p. iii 4. Series page - p. ii 5. Copyright - p. iv 6. Contributors - p. v 7. Series Foreword - p. ix 8. Preface - p. xi 9. Section A Infectious Disease - p. xi 10. Chapter 1 Management of the Asymptomatic Newborn at Risk for Sepsis - p. 3 11. Chapter 2 Empiric Antimicrobials for Neonatal Sepsis - p. 15 12. Chapter 3 When and How to Treat Neonatal CMV Infection - p. 27 13. Chapter 4 Neonatal Herpes Simplex Virus Infection - p. 37 14. Chapter 5 Antibiotic Stewardship - p. 45 15. Chapter 6 Candida Prophylaxis - p. 63 16. Chapter 7 Diagnosis, Risk Factors, Outcomes, and Evaluation of Invasive Candida Infections - p. 69 17. Chapter 8 When to Perform Lumbar Puncture in Infants at Risk for Meningitis in the Neonatal Intensive Care Unit - p. 87 18. Chapter 9 Biomarkers in the Diagnosis of Neonatal Sepsis - p. 103 19. Chapter 10 Congenital Zika Syndrome - p. 113 20. Section B Pharmacology - p. 120 21. Chapter 11 Pharmacokinetic Considerations in Neonates - p. 123 22. Chapter 12 Neonatal Pharmacogenetics - p. 141 23. Chapter 13 Antibiotic Considerations for Necrotizing Enterocolitis - p. 155 24. Chapter 14 Antibiotic Dosing Considerations for Term and Preterm Infants - p. 167 25. Chapter 15 Antifungal Dosing Considerations for Term and Preterm Infants - p. 185 26. Chapter 16 Antiviral Dosing Considerations for Term and Preterm Infants - p. 193 27. Chapter 17 Antiepileptic Drug Therapy in Neonates - p. 207 28. Chapter 18 Neuroprotective Therapies in Infants - p. 227 29. Chapter 19 Pharmacologic Therapy for Neonatal Abstinence Syndrome - p. 243 30. Chapter 20 Therapies for Gastroesophageal Reflux in Infants - p. 261 31. Index - p. 279
No hay muestra disponible
No hay ficha técnica disponible
